市場調査レポート

商品コード

1504259

圧迫療法の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）

Compression Therapy Market Assessment, By Product, By Technology, By Applications, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月01日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 667,485円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 845,481円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,216,306円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.33円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の圧迫療法の市場規模は、2023年の40億1,000万米ドルから2031年に59億4,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで5.03％の成長が見込まれます。市場の成長は、リンパ浮腫の患者数の増加、新製品の発売、戦略的提携やパートナーシップ、スポーツ傷害の増加などに支えられています。

脚潰瘍、静脈瘤、リンパ浮腫などのさまざまな症状の効果的な管理と治療における圧迫療法の利点に対する認識の高まりは、市場に有利な成長機会をもたらしています。医療従事者も、深部静脈血栓症のリスクが高い患者を含む他のさまざまな症状に対して圧迫療法を推奨しています。さまざまな流通チャネルで圧迫療法製品が入手可能になりつつあることは、これらの製品を簡単に調達できるようにすることで消費者の利便性を高め、市場の成長にプラスの影響を与えています。

先進の製品やソリューションの開発、米国食品医薬品局（FDA）からの認可取得は、市場の拡大をさらに後押ししています。2023年4月、Airos Medical, Inc.はAIROS 8P Sequential Compression Therapy garment system and deviceの米国FDA 510（k）認可を取得しました。この認可により、Airosは腹部腫脹を治療するための下腿三頭筋用ガーメントを提供できるようになっています。このガーメントは、臀部、下腿、背中、腹部にリンパ浮腫を持つ患者に最適です。AIROS 8Pはまた、アップグレードされたAC100～240Vの電気機能と大型のエアポンプを備えており、世界中のさまざまな地域でこの機器を使用できるようにし、特にアジア太平洋や欧州などの地域での製品の拡大への道を開きます。このような開発と認可は、企業の拡大を助け、世界の圧迫療法市場の需要を増大させると予測されます。

スポーツ傷害の増加が市場需要を強化

子供やティーンエイジャーの間でスポーツ活動の採用が増加しており、これらの活動への参加は怪我の可能性を増大させ、治療ソリューションの必要性を高めることから、圧迫療法の需要が高まっています。子供やティーンエイジャーの体力向上や、人格形成、自尊心やリーダーシップスキルの向上など、スポーツ活動がもたらすさまざまな利点に対する認識が高まっているため、親はスポーツ活動への参加を奨励しています。このような参加の増加は、スポーツに関連した怪我の発生によって引き起こされる可能性のある疼痛を効果的に管理する圧迫療法への要求を増大させています。Johns Hopkins Medicineの推計によると、米国では約3,000万人のティーンエイジャーや子供が組織化されたスポーツに参加しており、子供時代に負った怪我の約3分の1はスポーツが原因です。この増加により、腫れや炎症を抑え、外傷を取り囲む軟部組織の内部損傷を軽減するさまざまな圧迫療法への需要が高まっています。

新製品の発売が市場成長を後押し

新製品の発売は、消費者の快適性を高め、より高い効果を提供する製品の利用可能性を強化し、企業が顧客基盤を拡大できるようにすることから、世界の圧迫療法市場の成長を促進すると予測されます。2024年2月、非侵襲性の患者モニタリング、疼痛管理、リハビリテーション医療機器の販売と製造を専門とする革新的医療技術の主要企業であるZynex, Inc.は、Zynex DynaComp Cold CompressionとZynex Pro Hybrid LSOを発表しました。前者は、圧迫と冷却療法を組み合わせて回復を早めるもので、携帯に便利なコンパクトサイズで、外出先でも炎症や痛み、腫れを緩和することができます。そのため、患者の回復が早まり、日常生活を楽に再開できるようになります。このような取り組みにより、企業は持続的な成長を確保し、収益源を多様化することができ、成長を促進し、市場の拡大を支えています。

当レポートでは、世界の圧迫療法市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
製品別
- 圧迫テープ
- 圧迫ストッキング
- 圧迫ラップ
- 圧迫包帯
- 圧迫ブレース
- 圧迫ポンプ
- その他
技術別
- 静的圧迫療法
- 動的圧迫療法
用途別
- リンパ浮腫の治療
- 静脈瘤の治療
- 脚潰瘍の治療
- 深部静脈血栓症の治療
- その他
エンドユーザー別
- 病院、診療所
- 在宅医療
- 介護施設
- その他
流通チャネル別
- eコマースプラットフォーム
- 病院薬局
- 小売薬局
地域別
- 北米
- 南米
- 欧州
- アジア太平洋
- 中東・アフリカ
市場シェア：企業別（2023年）

第5章世界の圧迫療法市場の見通し：地域別（2017年～2031年）

北米
- 市場規模と予測
- 製品別
- 技術別
- 用途別
- エンドユーザー別
- 流通チャネル別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
南米
- ブラジル
- アルゼンチン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第6章市場マッピング（2023年）

疾患製品別
技術別
用途別
エンドユーザー別
流通チャネル別
地域別

第7章マクロ環境と産業構造

需給分析
輸入輸出分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第9章規制枠組みとイノベーション

臨床試験
特許情勢
規制当局の承認
イノベーション/新技術

第10章主要企業の情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益の分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場企業5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

3M COMPANY
Bio Compression Systems, Inc.
medi GmbH & Co KG.
SIGVARIS AG
Paul Hartmann AG
Julius Zorn GmbH
Gottfried Medical, Inc.
Smith & Nephew plc
DJO, LLC
ARJO HUNTLEIGH INTERNATIONAL LIMITED

第14章戦略的推奨

第15章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 4. Global Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 5. Global Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 6. Global Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 7. Global Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 8. Global Compression Therapy Market Share (%), By Region, 2017-2031F
Figure 9. North America Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 12. North America Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 13. North America Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 14. North America Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 15. North America Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 16. North America Compression Therapy Market Share (%), By Country, 2017-2031F
Figure 17. United States Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 20. United States Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 21. United States Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 22. United States Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 23. United States Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 24. Canada Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 27. Canada Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 28. Canada Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 29. Canada Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 30. Canada Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 31. Mexico Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 34. Mexico Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 35. Mexico Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 36. Mexico Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 37. Mexico Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 38. Europe Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 41. Europe Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 42. Europe Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 43. Europe Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 44. Europe Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 45. Europe Compression Therapy Market Share (%), By Country, 2017-2031F
Figure 46. Germany Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 49. Germany Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 50. Germany Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 51. Germany Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 52. Germany Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 53. France Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 55. France Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 56. France Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 57. France Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 58. France Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 59. France Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 60. Italy Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 63. Italy Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 64. Italy Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 65. Italy Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 66. Italy Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 67. United Kingdom Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 70. United Kingdom Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 71. United Kingdom Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 72. United Kingdom Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 73. United Kingdom Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 74. Russia Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 77. Russia Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 78. Russia Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 79. Russia Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 80. Russia Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 81. Netherlands Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 84. Netherlands Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 85. Netherlands Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 86. Netherlands Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 87. Netherlands Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 88. Spain Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 91. Spain Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 92. Spain Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 93. Spain Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 94. Spain Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 95. Turkey Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 98. Turkey Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 99. Turkey Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 100. Turkey Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 101. Turkey Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 102. Poland Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 105. Poland Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 106. Poland Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 107. Poland Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 108. Poland Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 109. South America Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 112. South America Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 113. South America Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 114. South America Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 115. South America Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 116. South America Compression Therapy Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 120. Brazil Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 121. Brazil Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 122. Brazil Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 123. Brazil Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 124. Argentina Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 127. Argentina Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 128. Argentina Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 129. Argentina Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 130. Argentina Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 131. Asia-Pacific Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 134. Asia-Pacific Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 135. Asia-Pacific Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 136. Asia-Pacific Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 137. Asia- Pacific Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 138. Asia-Pacific Compression Therapy Market Share (%), By Country, 2017-2031F
Figure 139. India Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 141. India Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 142. India Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 143. India Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 144. India Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 145. India Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 146. China Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 148. China Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 149. China Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 150. China Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 151. China Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 152. China Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 153. Japan Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 156. Japan Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 157. Japan Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 158. Japan Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 159. Japan Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 160. Australia Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 163. Australia Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 164. Australia Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 165. Australia Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 166. Australia Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 167. Vietnam Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 170. Vietnam Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 171. Vietnam Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 172. Vietnam Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 173. Vietnam Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 174. South Korea Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 177. South Korea Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 178. South Korea Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 179. South Korea Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 180. South Korea Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 181. Indonesia Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 184. Indonesia Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 185. Indonesia Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 186. Indonesia Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 187. Indonesia Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 188. Philippines Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 191. Philippines Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 192. Philippines Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 193. Philippines Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 194. Philippines Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 195. Middle East & Africa Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 198. Middle East & Africa Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 199. Middle East & Africa Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 200. Middle East & Africa Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 201. Middle East & Africa Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 202. Middle East & Africa Compression Therapy Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 206. Saudi Arabia Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 207. Saudi Arabia Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 208. Saudi Arabia Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 209. Saudi Arabia Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 210. UAE Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 213. UAE Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 214. UAE Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 215. UAE Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 216. UAE Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 217. South Africa Compression Therapy Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Compression Therapy Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa Compression Therapy Market Share (%), By Product, 2017-2031F
Figure 220. South Africa Compression Therapy Market Share (%), By Technology, 2017-2031F
Figure 221. South Africa Compression Therapy Market Share (%), By Applications, 2017-2031F
Figure 222. South Africa Compression Therapy Market Share (%), By End-user, 2017-2031F
Figure 223. South Africa Compression Therapy Market Share (%), By Distribution Channel, 2017-2031F
Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11535

Global compression therapy market is projected to witness a CAGR of 5.03% during the forecast period 2024-2031, growing from USD 4.01 billion in 2023 to USD 5.94 billion in 2031F. The growth of the market is aided by the growing cases of lymphedema, novel product launches, strategic collaborations and partnerships, and a rise in the number of sports-related injuries.

The growing awareness about the advantages of compression therapies in the effective management and treatment of various conditions, such as leg ulcers, varicose veins, and lymphedema, among others, is providing lucrative growth opportunities to the market. Healthcare professionals also recommend compression therapy for various other conditions, including those at a high risk of deep vein thrombosis. The rising availability of compression therapy products across different distribution channels enhances consumer convenience by allowing easy procurement of these products, positively influencing the growth of the market.

The development of advanced products and solutions and receipt of clearance from the U.S. Food and Drug Administration (FDA) further support the expansion of the market. In April 2023, Airos Medical, Inc. received U.S. FDA 510(k) clearance to market their AIROS 8P Sequential Compression Therapy garment system and device. This clearance allowed AIROS to provide lower truncal garments to treat abdominal swelling. The garment is ideal for patients with lymphedema in their hips, lower legs, back, and abdomen. The AIROS 8P also features upgraded 100-240 VAC electrical capabilities and a larger air pump, allowing the device to be used in different regions across the globe and paving the way for the expansion of the product in regions such as Asia-Pacific and Europe, among others. Such developments and clearances are expected to aid the expansion of the companies and augment the global compression therapy market demand.

Rising Sports Injuries Bolsters Market Demand

The rising adoption of sports activities among children and teenagers propels the demand for compression therapy as participation in these activities augments the chances of injuries and boosts the requirement for treatment solutions. Due to the growing awareness about the various advantages offered by these activities in improving the physical fitness of children and teenagers while positively influencing their personal development and increasing self-esteem and leadership skills, parents are encouraging participation in these activities. This increased participation augments the requirement for compression therapy for the effective management of pain that can be caused by the occurrence of sports-related injuries. According to estimates from Johns Hopkins Medicine, approximately 30 million teenagers and children participate in organized sports in the United States and about one-third of the injuries procured during childhood are caused by sports. This increase is propelling the requirement for various compression therapies as they aid in reducing swelling and inflammation and also reduce internal injuries in the soft tissue that surrounds the external injury.

New Product Launches Boost Market Growth

Novel product launches are expected to fuel the global compression therapy market growth as they enhance consumer comfort and bolster the availability of products that offer enhanced effectiveness, allowing businesses to expand their customer base. In February 2024, Zynex, Inc., one of the leading innovative medical technology companies that specialize in the sale and manufacture of non-invasive patient monitoring, pain management, and rehabilitation medical devices, introduced Zynex DynaComp Cold Compression and Zynex Pro Hybrid LSO. The former combines compression and cold therapy to accelerate recovery time, and its portable and compact nature makes it easy to carry, providing on-the-go muscle relief from inflammation, soreness, and swelling. Thus, aiding patients in recovering faster and allowing them to restart their daily schedules with ease. Such efforts allow companies to ensure sustained growth and diversify revenue streams, propelling their growth and supporting the expansion of the market.

North America Anticipated to Account for Significant Market Share

Rising government initiatives support the growth of the market in North America, the growing prevalence of chronic diseases, new product launches, the rising number of sports-related injuries, and increasing investments in research and development activities. In November 2022, the U.S. House of Representatives passed H.R. 3630, the Lymphedema Treatment Act. This bill will improve the accessibility of medical compression garments for patients with lymphedema who rely on the products for treating their swelling. The utilization of medical compression garments aids in improving the quality of life and health of patients by reducing the requirement for hospitalization and the risk of infections, while protecting the patients from various complications. The federal law was passed in December 2022 and went into effect in January 2024 to improve the insurance coverage of prescribed compression supplies essential for treating lymphedema.

Additionally, the growing number of cases of diabetes and rising obesity in various countries in North America are further supporting the expansion of the market in the region, as such conditions often lead to circulatory issues, resulting in an increased demand for compression therapy products. According to estimates from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 11.6% of the population of the United States had diabetes in 2021.

Compression Bandages Hold Significant Global Compression Therapy Market Share

The segment's growth can be attributed to the expansion of the geriatric population and rising cases of diabetes, varicose veins, and foot ulcers in various regions across the globe. According to the estimates of the International Diabetes Federation (IDF), by 2045, approximately 783 million individuals will be living with diabetes. Compression bandages are the gold standard for treating underlying venous insufficiency and managing venous leg ulceration.

Furthermore, the rising studies to assess the effectiveness of compression bandaging are also providing lucrative growth opportunities to the market and supporting the segment's expansion. For instance, an observational study is being conducted to evaluate the effectiveness of compression bandaging in patients suffering from chronic edema. The CIMON sensor is developed for monitoring and placed in the calf's widest circumference, allowing it to measure the difference in capacitance. The study is expected to conclude in December 2025.

Future Market Scenario (2024-2031F)

According to the global compression therapy market analysis, the market is expected to witness significant growth in the coming years owing to rising cases of diabetes, obesity, venous ulcers, lymphedema, and varicose veins, among others. Efforts are being made to improve compression therapy so that clinicians are able to treat their patients in a time-efficient manner while enhancing their comfort. The growing availability of compression products, along with increasing cases of sports-related injuries, are also expected to offer lucrative growth opportunities to the market. The rising investments in research studies are also expected to bolster the growth of the market as these studies aid in examining and assessing the benefits offered by different compression therapies. For instance, the Massachusetts General Hospital is conducting a pilot study on compression sleeve intervention for patients that are at high risk of breast cancer-related lymphedema. The study is expected to conclude in June 2025 and will also have a compression sleeve with a sensor for capturing patient adherence to the pressure applied and compression wear.

Key Players Landscape and Outlook

Strategic collaborations and partnerships are expected to boost the global compression therapy market size in the coming years. In October 2023, MediWound Ltd. announced partnership with 3M COMPANY for phase 3 study of their leading drug candidate EscharEx, indicated for treating patients having venous leg ulcers. The company will be using two-layer compression systems Coban 2 Lite and Coban 2 by 3M during the wound healing and debridement phases of the study. The entry of the topical biologic drug developed for removing nonviable wound tissues for patients with chronic wounds into Phase 3 study is expected to happen in 2024.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Compression Therapy Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product
- 4.2.1. Compression Tapes
- 4.2.2. Compression Stockings
  - 4.2.2.1. Class I
  - 4.2.2.2. Class II
  - 4.2.2.3. Class III
- 4.2.3. Compression Wraps
- 4.2.4. Compression Bandages
- 4.2.5. Compression Braces
- 4.2.6. Compression Pumps
  - 4.2.6.1. Intermittent Pumps
  - 4.2.6.2. Sequential Pumps
- 4.2.7. Others
4.3. By Technology
- 4.3.1. Static Compression Therapy
- 4.3.2. Dynamic Compression Therapy
4.4. By Applications
- 4.4.1. Lymphedema Treatment
- 4.4.2. Varicose Vein Treatment
- 4.4.3. Leg Ulcer Treatment
- 4.4.4. Deep Vein Thrombosis Treatment
- 4.4.5. Others
4.5. By End-user
- 4.5.1. Hospitals and Clinics
- 4.5.2. Home Healthcare
- 4.5.3. Nursing Homes
- 4.5.4. Others
4.6. By Distribution Channel
- 4.6.1. E-Commerce Platforms
- 4.6.2. Hospital Pharmacies
- 4.6.3. Retail Pharmacies
4.7. By Region
- 4.7.1. North America
- 4.7.2. South America
- 4.7.3. Europe
- 4.7.4. Asia-Pacific
- 4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023

5. Global Compression Therapy Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product
  - 5.1.2.1. Compression Tapes
  - 5.1.2.2. Compression Stockings
    - 5.1.2.2.1. Class I
    - 5.1.2.2.2. Class II
    - 5.1.2.2.3. Class III
  - 5.1.2.3. Compression Wraps
  - 5.1.2.4. Compression Bandages
  - 5.1.2.5. Compression Braces
  - 5.1.2.6. Compression Pumps
    - 5.1.2.6.1. Intermittent Pumps
    - 5.1.2.6.2. Sequential Pumps
  - 5.1.2.7. Others
- 5.1.3. By Technology
  - 5.1.3.1. Static Compression Therapy
  - 5.1.3.2. Dynamic Compression Therapy
- 5.1.4. By Applications
  - 5.1.4.1. Lymphedema Treatment
  - 5.1.4.2. Varicose Vein Treatment
  - 5.1.4.3. Leg Ulcer Treatment
  - 5.1.4.4. Deep Vein Thrombosis Treatment
  - 5.1.4.5. Others
- 5.1.5. By End-user
  - 5.1.5.1. Hospitals and Clinics
  - 5.1.5.2. Home Healthcare
  - 5.1.5.3. Nursing Homes
  - 5.1.5.4. Others
- 5.1.6. By Distribution Channel
  - 5.1.6.1. E-Commerce Platforms
  - 5.1.6.2. Hospital Pharmacies
  - 5.1.6.3. Retail Pharmacies
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
    - 5.1.7.1.1. By Value
    - 5.1.7.1.2. By Volume
  - 5.1.7.2. By Product
    - 5.1.7.2.1. Compression Tapes
    - 5.1.7.2.2. Compression Stockings
      - 5.1.7.2.2.1. Class I
      - 5.1.7.2.2.2. Class II
      - 5.1.7.2.2.3. Class III
    - 5.1.7.2.3. Compression Wraps
    - 5.1.7.2.4. Compression Bandages
    - 5.1.7.2.5. Compression Braces
    - 5.1.7.2.6. Compression Pumps
      - 5.1.7.2.6.1. Intermittent Pumps
      - 5.1.7.2.6.2. Sequential Pumps
    - 5.1.7.2.7. Others
  - 5.1.7.3. By Technology
    - 5.1.7.3.1. Static Compression Therapy
    - 5.1.7.3.2. Dynamic Compression Therapy
  - 5.1.7.4. By Applications
    - 5.1.7.4.1. Lymphedema Treatment
    - 5.1.7.4.2. Varicose Vein Treatment
    - 5.1.7.4.3. Leg Ulcer Treatment
    - 5.1.7.4.4. Deep Vein Thrombosis Treatment
    - 5.1.7.4.5. Others
  - 5.1.7.5. By End-user
    - 5.1.7.5.1. Hospitals and Clinics
    - 5.1.7.5.2. Home Healthcare
    - 5.1.7.5.3. Nursing Homes
    - 5.1.7.5.4. Others
  - 5.1.7.6. By Distribution Channel
    - 5.1.7.6.1. E-Commerce Platforms
    - 5.1.7.6.2. Hospital Pharmacies
    - 5.1.7.6.3. Retail Pharmacies
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Disease Product
6.2. By Technology
6.3. By Applications
6.4. By End-user
6.5. By Distribution Channel
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. 3M COMPANY
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Bio Compression Systems, Inc.
13.3. medi GmbH & Co KG.
13.4. SIGVARIS AG
13.5. Paul Hartmann AG
13.6. Julius Zorn GmbH
13.7. Gottfried Medical, Inc.
13.8. Smith & Nephew plc
13.9. DJO, LLC
13.10. ARJO HUNTLEIGH INTERNATIONAL LIMITED

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

圧迫療法の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）

Compression Therapy Market Assessment, By Product, By Technology, By Applications, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の圧迫療法市場の見通し（2017年～2031年）

第5章世界の圧迫療法市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Compression Therapy Market Outlook, 2017-2031F

5. Global Compression Therapy Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

圧迫療法の世界市場の評価：製品別、技術別、用途別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）

Compression Therapy Market Assessment, By Product, By Technology, By Applications, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の圧迫療法市場の見通し（2017年～2031年）

第5章 世界の圧迫療法市場の見通し：地域別（2017年～2031年）

第6章 市場マッピング（2023年）

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的推奨

第15章 当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Compression Therapy Market Outlook, 2017-2031F

5. Global Compression Therapy Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の圧迫療法市場の見通し（2017年～2031年）

第5章世界の圧迫療法市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項